ÖZASLAN, A. Et Al. 2022. Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.20, no.1 , 109-117.

ÖZASLAN, A., GÜNEY, E., GÜLBAHAR, Ö., Buyuktaskin, D., & Arslan, B., (2022). Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.20, no.1, 109-117.

ÖZASLAN, AHMET Et Al. "Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines," CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.20, no.1, 109-117, 2022

ÖZASLAN, AHMET Et Al. "Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines." CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.20, no.1, pp.109-117, 2022

ÖZASLAN, A. Et Al. (2022) . "Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines." CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.20, no.1, pp.109-117.

@article{article, author={AHMET ÖZASLAN Et Al. }, title={Increased Serum Level of CCL5 in Children with Attention-Deficit/Hyperactivity Disorder: First Results about Serum Chemokines}, journal={CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE}, year=2022, pages={109-117} }